abstract |
The present disclosure relates to compositions comprising the HIV-1 fusion inhibitor Avvavit, including liquid compositions and stable lyophilized compositions. The present disclosure also provides processes for their preparation, and the use of these compositions for preventing, treating or preventing diseases caused by HIV. |